Colorectal Cancer Coverage from Every Angle

Recent News

GI Cancers Symposium 2020: Sociodemographic Disparities and Outcomes in Young Adults With Colorectal Cancer
Fasting Prior to Chemotherapy for Colorectal Cancer Under Study
Did Changes in American Cancer Society Guidelines Impact Colorectal Cancer Screening Patterns?
Is There a Prognostic Role for CDH1 Variants in Colorectal Cancer?
Priority Review Granted by FDA for Combination Therapy in Metastatic Colorectal Cancer
Bioinformatic Analysis of Progression of Colorectal Cancer
New Guideline Recommends Using 15-Year Risk in Colorectal Cancer Screening
Insurance and Mortality in Colorectal and Other Cancers
ACS 2019: Short-Term Survival in Elderly Patients Undergoing Surgery for Colon Cancer
SITC 2019: Avelumab Plus FOLFOX and Cetuximab in Metastatic Colorectal Cancer
Tumor Cell PD-L1 May Regulate Chemotherapy-Induced Apoptosis in Colorectal Cancer
Investigational Drug Under Study in KRAS G12C–Mutant Colorectal Cancer
ACG 2019: Prevalence of Advanced Polyps in Average-Risk Populations
ACG 2019: Does Body Weight Impact Colorectal Cancer Survival?
Novel Potential Mechanism of Resistance to EGFR Inhibition in Colorectal Cancer
ESMO 2019: Novel Mutated Genes May Alter Responses to Therapy in Colorectal Cancer
ESMO 2019: Circulating Tumor DNA as Predictive Biomarker of Relapse in Colorectal Cancer
Role of Patient Navigation in Screening for Colorectal Cancer in Underserved Areas
ESMO 2019: Triplet Therapy for Advanced BRAF-Mutated Colorectal Cancer
AACR Disparities 2019: Racial Differences in Mortality From Colorectal Cancer in U.S. Cities
FDA Expands Indication for Colorectal Cancer Screening Test: Aged 45 and Older
How Useful Are Screening and Stepped Care Programs in Patients With Colorectal Cancer?
Is Use of Oral Antibiotics Linked to Increased Risk for Colon or Rectal Cancer?
LifeKit Prevent Colorectal Neoplasia Test Granted Breakthrough Device Designation
Quality Care 2019: Initiative to Reduce CSF Overuse in Patients With Colorectal Cancer
RasGRP1: Potential Biomarker of Therapeutic Response in Colorectal Cancer?
Why Are More Patients Younger Than Age 50 Developing Colorectal Cancer?
FOxTROT Trial: Neoadjuvant Chemotherapy for Operable Colon Cancer
FOLFOXIRI Plus Bevacizumab in Unresectable Coloretcal Cancer: Update From TRIBE2
Fight CRC Publishes Collaborative Summary on Early-Onset Colorectal Cancer
ctDNA May Offer Clues to Prognosis in Patients With Rectal Cancer
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.